Substance Consumption, Personality, and Cognitive Functioning of Chess Players

Depression Clinical Trial

Official title:

Substance Consumption, Personality, and Cognitive Functioning of Chess Players and Non-chess Players - an Online Survey

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06346353
• Other study ID #: Chess Cognition SUD
• Status: Recruiting
• Start date: January 31, 2024
• Est. completion date: May 31, 2024

Study information

• Verified date: March 2024
• Source: Central Institute of Mental Health, Mannheim
• Contact: Sabine Vollstädt-Klein, Prof. Dr.
• Phone: +49-621/1703
• Email: s.vollstaedt-klein[@]zi-mannheim.de
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of this project is to find out if there is a difference in addictive behavior, personality traits, and cognitive abilities between chess players and non-chess players.

Description:

In the present planned study, tournament chess players will be compared with non-tournament chess playing individuals by means of an online survey. Among other things, the investigators want to investigate whether these groups of persons differ in various characteristics such as their consumption behavior (alcohol, tobacco, and drug use), their personality, their depressiveness and mood, or their cognitive abilities. The background is the question whether playing chess could be protective against substance use disorders or could mitigate the manifestation.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 910
• Est. completion date: May 31, 2024
• Est. primary completion date: May 31, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• all persons from the age of 18 years
• Inclusion in the group of chess players is based on the existence of a DWZ.
• Sufficient ability to answer the questionnaires

Exclusion Criteria:

• None

Related Conditions & MeSH terms

• Addiction
• Alcohol
• Anxiety
• Depression
• Drugs
• Nicotine
• Personality
• Personality Disorders

Locations

Country	Name	City	State
Germany	Klinik für Abhängiges Verhalten, Zentralinstitut für Seelische Gesundheit	Mannheim

Sponsors (1)

Lead Sponsor	Collaborator
Central Institute of Mental Health, Mannheim

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Substance Craving	Mannheimer Craving Scale (MACS), Nakovics, Diehl, Geiselhart, & Mann, 2009	baseline
Primary	Alcohol Use	Alcohol Use Disorders Indentification Scale (AUDIT-C), Bohn, Babor, & Kranzler, 1995	baseline
Primary	Automatic Alcohol Craving	Craving Automated Scale - Alcohol (CAS-A), Vollstädt-Klein, Leménager, Jorde, Kiefer, & Nakovics, 2015	baseline
Primary	Severity of Nicotine Dependence	Fagerstrom Test of Nicotine Dependence (FTND), Heatherton, Kozlowski, Frecker, & Fagerström, 1991	baseline
Primary	Automatic Cigarette Craving	Craving Automated Scale - Cigarette Smoking (CAS-CS), Tan et al., 2022	baseline
Primary	Smoking Consequences	Smoking Consequences Questionnaire (SCQ), Lewis-Esquerre, Rodrigue, & Kahler, 2005	baseline
Primary	Drug Abuse	Drug Abuse Screening Test (DAST-10), Lam et al., 2015	baseline
Primary	Personality	NEO five factor inventory (NEO-FFI), Körner et al., 2008	baseline
Primary	Depression	Beck Depressions Inventar - II (BDI-II) Kühner, Bürger, Keller, & Hautzinger, 2007	baseline
Primary	Anxiety	State Trait Anxiety Inventory (STAI - trait Version), Spielberger, 1983	baseline
Primary	self-efficacy	Self-efficacy expectancy (SWE) Jerusalem & Schwarzer, 1999	baseline
Primary	coping with stress	Brief COPE, Carver, Scheier, & Weintraub, 1989	baseline
Primary	Inhibition capacity	Stop Signal Task (Sebastian et al., 2013)	baseline
Primary	Working Memory capacity	N-back Task (Charlet et al., 2014)	baseline